Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis

被引:2
作者
Groen, Kira [1 ,2 ]
Lechner-Scott, Jeannette [1 ,2 ]
Pohl, Daniela [3 ]
Levy, Michael [4 ]
Giovannoni, Gavin [5 ]
Hawkes, Chris [6 ]
机构
[1] Univ Newcastle, Hunter Med Researc Inst, Newcastle, NSW, Australia
[2] Hunter New England Area Hlth, Newcastle, NSW, Australia
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Dept Neurol, London, England
[6] Queen Mary Univ London, Dept Neurol, Neurosci Ctr, London, England
关键词
WHITE-MATTER LESIONS; NEUROMYELITIS-OPTICA; SPECTRUM;
D O I
10.1016/j.msard.2021.102931
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 28 条
[1]   Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? [J].
Abdelhak, Ahmed ;
Hottenrott, Tilman ;
Morenas-Rodriguez, Estrella ;
Suarez-Calvet, Marc ;
Zettl, Uwe K. ;
Haass, Christian ;
Meuth, Sven G. ;
Rauer, Sebastian ;
Otto, Markus ;
Tumani, Hayrettin ;
Huss, Andre .
FRONTIERS IN NEUROLOGY, 2019, 10
[2]   Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker [J].
Aktas, Orhan ;
Smith, Michael A. ;
Rees, William A. ;
Bennett, Jeffrey L. ;
She, Dewei ;
Katz, Eliezer ;
Cree, Bruce A. C. .
ANNALS OF NEUROLOGY, 2021, 89 (05) :895-910
[3]   Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients [J].
Al-iedani, Oun ;
Ribbons, Karen ;
Gholizadeh, Neda ;
Lechner-Scott, Jeannette ;
Quadrelli, Scott ;
Lea, Rodney ;
Andronesi, Ovidiu ;
Ramadan, Saadallah .
MAGNETIC RESONANCE IMAGING, 2020, 74 :21-30
[4]   Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study [J].
Altermatt, Anna ;
Gaetano, Laura ;
Magon, Stefano ;
Bauer, Lorena ;
Feurer, Regina ;
Gnahn, Hans ;
Hartmann, Julia ;
Seifert, Christian L. ;
Poppert, Holger ;
Wuerfel, Jens ;
Radue, Ernst-Wilhelm ;
Kappos, Ludwig ;
Sprenger, Till .
NEUROIMAGE, 2019, 189 :727-733
[5]   DNA methylation aging clocks: challenges and recommendations [J].
Bell, Christopher G. ;
Lowe, Robert ;
Adams, Peter D. ;
Baccarelli, Andrea A. ;
Beck, Stephan ;
Bell, Jordana T. ;
Christensen, Brock C. ;
Gladyshev, Vadim N. ;
Heijmans, Bastiaan T. ;
Horvath, Steve ;
Ideker, Trey ;
Issa, Jean-Pierre J. ;
Kelsey, Karl T. ;
Marioni, Riccardo E. ;
Reik, Wolf ;
Relton, Caroline L. ;
Schalkwyk, Leonard C. ;
Teschendorff, Andrew E. ;
Wagner, Wolfgang ;
Zhang, Kang ;
Rakyan, Vardhman K. .
GENOME BIOLOGY, 2019, 20 (01)
[6]   Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients [J].
Dalla Costa, Gloria ;
Martinelli, Vittorio ;
Moiola, Lucia ;
Sangalli, Francesca ;
Colombo, Bruno ;
Finardi, Annamaria ;
Cinque, Paola ;
Kolb, Eva-Maria ;
Haghikia, Aiden ;
Gold, Ralf ;
Furlan, Roberto ;
Comi, Giancarlo .
ANNALS OF NEUROLOGY, 2019, 85 (04) :606-610
[7]  
Fox R.J., 2021, MULT SCLER
[8]   Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis [J].
Giarraputo, James ;
Giamberardino, Stephanie ;
Arvai, Stephanie ;
Maichle, Sarah ;
Eckstein, Christopher ;
Newby, L. Kristin ;
Gregory, Simon .
JOURNAL OF NEUROIMMUNOLOGY, 2021, 354
[9]   Long-term prognostic value of longitudinal measurements of blood neurofilament levels [J].
Haring, Dieter A. ;
Kropshofer, Harald ;
Kappos, Ludwig ;
Cohen, Jeffrey A. ;
Shah, Anuja ;
Meinert, Rolf ;
Leppert, David ;
Tomic, Davorka ;
Kuhle, Jens .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (05)
[10]  
Hawkes C, 2021, Mult Scler Relat Disord, V47